chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary pain, Pyrexia, Tremor
Clinical narrative: Fever; chills; shaking; cold; sweating; no appetite; exhaustion; sore throat; lung pain; burning sensation; shooting pain; nightmares; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 16:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic asthma and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not have a history of allergies to medications, food or other products. Concomitant medications included paracetamol (TYLENOL) for an unknown indication from an unknown date. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 05Mar2021 at 17:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 27Mar2021 at 11:00, the patient experienced fever 102.5 (unspecified units), chills/shaking, cold, sweating, no appetite, exhaustion, sore throat, lung pain (burning sensation and shooting pain) and nightmares. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcomes of the events fever 102.5, chills/shaking, cold, sweating, no appetite, exhaustion, sore throat, lung pain (burning sensation and shooting pain) and nightmares was recovered in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Chills, Fatigue, Headache
Clinical narrative: slight headache; heavy chills; temperature 100.7; tiredness; (This is a spontaneous report from a contactable consumer, the patient. A 80-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWA151) via an unspecified route of administration in the left arm on 10Apr2021 at 13:45 (at the age of 80-years-old), as a single dose for COVID-19 immunisation. Medical history included arthritis, thyroid, hypertension and known allergy to pain medications. The patient received unspecified medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:EP6955) via an unspecified route of administration in the left arm on 20Mar2021 at 14:30 (at the age of 80-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 10Apr2021, 10 hours after vaccine, the patient experienced slight headache, heavy chills, temperature 100.7 and tiredness. The patient underwent lab tests and procedures which included body temperature on 10Apr2021 and the result was 100.7 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event slight headache, heavy chills, temperature 100.7 and tiredness was recovered on unknown date of Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Somnolence
Clinical narrative: woke up the next day a bit groggy; woke up with terrible chills; followed by severe headache; body aches started around noon; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route of administration in right arm on 10Apr2021 at 12:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food, or other products. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Apr2021 at 04:00, the patient had experienced terrible chills, followed by severe headache, which lasted until about 09:00. The patient was then feeling a bit better but body aches had started around noon and headaches continued. Around 19:00, the patient got very bad chills again which lasted about 3 hours. The patient went to bed around 22:00 and had managed to fall asleep for a few hours until waking up with chills and a headache again. The patient finally fell asleep and woke up the next day a bit groggy on 12Apr2021, but the symptoms were gone. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit emergency room/department or urgent care. No therapeutic measures were taken as a result of adverse events. The clinical outcome of the events terrible chills, followed by severe headache, body aches were recovered on 12Apr2021 and the event woke up the next day a bit groggy was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Facial pain, Herpes zoster, Rash
Clinical narrative: Pain and rash in face, diagnosed with Shingles; Pain and rash in face, diagnosed with Shingles; Pain and rash in face, diagnosed with Shingles; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8733) via an unspecified route of administration in the left arm on 02Apr2021 at 09:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included losartan 100 milligram (MANUFACTURER UNKNOWN) from unknown date for unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 12:00 the patient experienced pain and rash in face, and was diagnosed with Shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of pain and rash in face, and Shingles and included treatment with Valacyclovir. The clinical outcome of the events pain and rash in face, diagnosed with Shingles was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pharyngeal paraesthesia
Clinical narrative: Tingling in the back of throat; Tingling in the face; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 13Apr2021 at 17:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and sulfa (sulfonamide) allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 13Apr2021 at 17:45, the patient experienced tingling in the face and back of throat. Since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tingling in the face and back of throat was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: with in 3.5 hours of shot my left pinky and outer left arm felt numbness; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number and Expiration date: unknown) via an unspecified route of administration in left arm on 13Apr2021 at 12:30 (age at vaccination 59-year-old) as single dose for covid-19 immunization. The patient medical history was none. Patient did not have any allergies to medications, food, or other products. The patient concomitant medication included acetylsalicylic acid [ASPIRIN (E.C.)] taken for an unspecified indication, start and stop date were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number and Expiration date: unknown) via an unspecified route of administration in left arm on 24Mar2021 at 03:00 PM as single dose for Covid-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to covid vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced within 3.5 hours of shot her left pinky and outer left arm felt numbness (on 13Apr2021 16:00. Patient did not receive any treatment for adverse event. The outcome of event was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Nausea, Pain
Clinical narrative: Body aches; Joint pain; Injection site pain; Nausea; Headache; Fatigue; Skin sensitivity (painful on touch); Skin sensitivity (painful on touch); This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 12Apr2021 at 18:15 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included tretinoin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Mar2021 as a single dose for COVID-19 immunisation. On 13Apr2021 at 10:00, the patient experienced body aches, joint pain, injection site pain, nausea, headache, fatigue and skin sensitivity which was painful on touch. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. The clinical outcome of events body aches, joint pain, injection site pain, nausea, headache, fatigue and skin sensitivity which was painful on touch were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Sensitive skin, Vaccination site pain
Clinical narrative: Body aches; Joint pain; Injection site pain; Nausea; Headache; Fatigue; Skin sensitivity (painful on touch); Skin sensitivity (painful on touch); This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 12Apr2021 at 18:15 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included tretinoin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Mar2021 as a single dose for COVID-19 immunisation. On 13Apr2021 at 10:00, the patient experienced body aches, joint pain, injection site pain, nausea, headache, fatigue and skin sensitivity which was painful on touch. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. The clinical outcome of events body aches, joint pain, injection site pain, nausea, headache, fatigue and skin sensitivity which was painful on touch were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Rash erythematous, Rash pruritic
Clinical narrative: 60% of body covered in red rash. Rash is warm to touch and not terribly itchy.; not terribly itchy; Rash is warm to touch; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0151) via an unspecified route of administration in the right arm on 08Apr2021 at 14:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia.  The patient previously first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6207) via an unspecified route of administration in the right arm on 18Mar2021 at 14:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Concomitant medications included ibuprofen sodium (IBUPROFEN), gabapentin (MANUFACTURER UNKNOWN) and oxycodone (MANUFACTURER UNKNOWN) all from unknown date for unspecified indications. The patient was having allergy to keflex.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 08:30 the patient experienced "60% of body covered in red rash. Rash was warm to touch and not terribly itchy" as reported. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the event(s). The clinical outcomes of the events red rash, warm to touch and not terribly itchy were not recovered.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Paraesthesia
Clinical narrative: Numbness in arm; Numbness in figures; Numbness in  hand; Tingling in figures, arm and hands; Pain in figures; Pain in arm; Pain in hand; This is a spontaneous report from a contactable consumer, the patient. A male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 24Mar2021 at 15:00 as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no allergies to food, medications or other products. Concomitant medications included finasteride (MANUFACTURER UNKNOWN) and travoprost (TRAVATAN Z), both for unknown indications form an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENU21) via an unspecified route of administration in the left arm on 03Mar2021 at 15:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021 shortly after the second vaccine shot the patient experienced numbness, tingling and excruciating pain at ''figures'', hands, arms when sitting and when sleeping patient was awakened by the pain. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events numbness, tingling and excruciating pain at ''figures'', hands and arms was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Ear discomfort, Ear pain, Fatigue
Clinical narrative: Nausea; fatigue; headache; dizzy; lower grade fever; occasional chills; right ear pain; strange sensation in ear; Tingling in face.; strange sensation in glands.; shaking of legs; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729), via an unspecified route of administration in the left arm on 08Apr2021 at 15:15 (at the age of 65-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient was allergic to penicillin and walnuts and sensitive to most drugs. The patient did not receive any other medications within two weeks prior to the vaccination. The patient previously received flu shot and experienced swelling of lips on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 17:00 the patient experienced nausea, fatigue, headache, dizzy, lower grade fever, occasional chills, right ear pain and strange sensation in it and glands and tingling in face. On 08Apr2021, first night of vaccination, the patient experienced shaking of legs for 15 minutes while in bed. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event nausea, fatigue, headache, dizzy, lower grade fever, occasional chills, right ear pain and strange sensation in it and glands and tingling in face was unknown. The clinical outcome of the event shaking of legs was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Nausea, Paraesthesia, Pyrexia
Clinical narrative: Nausea; fatigue; headache; dizzy; lower grade fever; occasional chills; right ear pain; strange sensation in ear; Tingling in face.; strange sensation in glands.; shaking of legs; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729), via an unspecified route of administration in the left arm on 08Apr2021 at 15:15 (at the age of 65-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient was allergic to penicillin and walnuts and sensitive to most drugs. The patient did not receive any other medications within two weeks prior to the vaccination. The patient previously received flu shot and experienced swelling of lips on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 17:00 the patient experienced nausea, fatigue, headache, dizzy, lower grade fever, occasional chills, right ear pain and strange sensation in it and glands and tingling in face. On 08Apr2021, first night of vaccination, the patient experienced shaking of legs for 15 minutes while in bed. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event nausea, fatigue, headache, dizzy, lower grade fever, occasional chills, right ear pain and strange sensation in it and glands and tingling in face was unknown. The clinical outcome of the event shaking of legs was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Nausea; fatigue; headache; dizzy; lower grade fever; occasional chills; right ear pain; strange sensation in ear; Tingling in face.; strange sensation in glands.; shaking of legs; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729), via an unspecified route of administration in the left arm on 08Apr2021 at 15:15 (at the age of 65-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient was allergic to penicillin and walnuts and sensitive to most drugs. The patient did not receive any other medications within two weeks prior to the vaccination. The patient previously received flu shot and experienced swelling of lips on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 17:00 the patient experienced nausea, fatigue, headache, dizzy, lower grade fever, occasional chills, right ear pain and strange sensation in it and glands and tingling in face. On 08Apr2021, first night of vaccination, the patient experienced shaking of legs for 15 minutes while in bed. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event nausea, fatigue, headache, dizzy, lower grade fever, occasional chills, right ear pain and strange sensation in it and glands and tingling in face was unknown. The clinical outcome of the event shaking of legs was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pyrexia
Clinical narrative: Horrible Migraine headache for 6 days; fever for 2 days; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration in the left arm on 05Mar2021 at 15:00 (at the age of 41-year-old), as a single dose and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736), via an unspecified route of administration in the right arm on 02Apr2021 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. Medical history included migraines but only have 1 headache ever 4 months and last for few hours and cured with medication and the patent had a history of allergy to yellow dye, diacetyl, spice allergy and banana. Concomitant medications included acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN MIGRAINE) and ascorbic acid, calcium carbonate, calcium pantothenate, calcium phosphate, chromium, cyanocobalamin, folic acid, magnesium carbonate, magnesium hydroxide, manganese gluconate, nicotinic acid, potassium bicarbonate, potassium carbonate, potassium phosphate dibasic, pyridoxine hydrochloride, quercetin, riboflavin sodium phosphate, sodium bicarbonate, sodium phosphate, thiamine hydrochloride, thioctic acid, zinc ascorbate (EMERGEN C) from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Mar2021 at 19:00, after the first dose the patient experienced horrible migraine headache for 6 days and fever for 2 days. After the second dose the patient had migraine for two days and fever for one day. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of events and included the treatment with Ubervly migraine drug. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event fever for 2 days following first dose was recovered on 07Mar2021. The clinical outcome of the event horrible migraine headache for 6 days following first dose was recovered on 11Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: i have had no symptoms since i got the vaccine today. after my first dose, i was very tired the 2 days following the vaccine (have since recovered); This is a spontaneous report from a non-contactable consumer, the patient. A 18-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 13Apr2021 at 13:00 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and COVID-19. Concomitant medications included fluoxetine hydrochloride (PROZAC) and birth control pill; all from an unknown date for an unknown indication. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On unknown date in Apr2021, she had no symptoms since she got the vaccine. after her first dose, the patient experienced very tired the 2 days following the vaccine (have since recovered). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event tiredness was recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen left lymph node in armpit area; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 09Apr2021 at 15:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not had allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 19Mar2021 at 16:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Apr2021, the patient experienced swollen left lymph node in armpit area. Therapeutic measures were taken as a result of the event and included treatment with ADVIL and ice. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen left lymph node in armpit area was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes virus infection
Clinical narrative: "herpes outbreak was starting to develop just below the center of lower lip. it has developed into a rather large multi-blister outbreak"; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 07Apr2021 at 12:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's thyroiditis. The patient did not receive any medication within two weeks of vaccination. The patient previously took Ibuprofen and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 18Mar2021 at 12:15 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, On the evening of the second day after the second vaccination, the patient noticed that a herpes outbreak had started to develop just below the center of her lower lip. Two days later, it had developed into large multi-blister outbreak- the worst that she had ever experienced. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event "herpes outbreak was starting to develop just below the center of lower lip and it developed into a rather large multi blister outbreak" was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Pain in extremity
Clinical narrative: Patients arm is achy from the should down through the finger tips of the left arm, up to the base of her head and spreads to her shoulder blade. All of this is to the left of her spine on the side the shot was administered.; Patients arm is achy from the should down through the finger tips of the left arm, up to the base of her head and spreads to her shoulder blade. All of this is to the left of her spine on the side the shot was administered.; Patients arm is achy from the should down through the finger tips of the left arm, up to the base of her head and spreads to her shoulder blade. All of this is to the left of her spine on the side the shot was administered.; This is a spontaneous report from a contactable consumer. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Information on other medical history and known allergies was not available. Concomitant medications taken within two weeks of vaccination included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), levothyroxine sodium (SYNTHROID), vitamin d nos (VITAMIN D), Bariatric Vitamin and biotin (MANUFACTURER UNKNOWN); all from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021 at 13:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 07:30, the patients arm was achy from the should down through the finger tips of the left arm, up to the base of her head and spread to her shoulder blade. All of this was to the left of her spine on the side the shot was administered. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events arm was achy from the should down through the finger tips of the left arm, up to the base of head and spread to shoulder blade was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Rash pruritic, Skin burning sensation
Clinical narrative: body rashes with itching and burning; body rashes with itching and burning; diarrhea; Tired; headeache; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 28Mar2021 at 17:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune disorder, penicillin allergy and sulfonamide allergy. Concomitant medications included thyroid (ARMOUR THYROID), progesterone (MANAFACTURER UNKNOWN) cream, testosterone (MANAFACTURER UNKNOWN) cream all from an unknown date for an unspecified indication. The patient previously took PABA (MANAFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021, the patient experienced tired and some headache for the first two days. On 30Mar2021 the patient experienced diarrhea and it was still happening, kept getting random headaches. On 05Apr2021, the patient experienced random body rashes with itching and burning that went away after taking antihistamines. That lasted three days, then started taking more antihistamine and did not happen for one day, but again a day later. Still had diarrhea and was exhausted. Patient stated that she felt great before getting the vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events random body rashes with itching and burning and included treatment with antihistamin. The clinical outcome of the events tired and some headache, diarrhea, random body rashes with itching and burning was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hypokinesia, Migraine, SARS-CoV-2 test
Clinical narrative: Unable to move; Migraine each day. Incapacitated for one week. Still get migraines out of the blue.; Chills; This is a spontaneous report from a contactable healthcare professional. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 09Mar2021 at 12:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease. Concomitant medications included SYNTHROID, vitamin d nos (MANUFACTURER UNKNOWN) for unknown indication since unknown date. The patient was allergic to milk products. The patient previously received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 16Feb2021 at 12:00 (at the age of 58-year-old) as a single dose for COVID-19. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Mar2021, second day the patient felt extremely ill unable to move except to go to the bathroom, chills, migraine each day which incapacitated for one week. Still get migraines out of the blue. Therapeutic measures were taken which included the treatment with eletriptan (MANUFACTURER UNKNOWN). On 23Mar2021, the patient underwent COVID-19 virus test and the result was Negative. On 06Apr2021, the patient underwent COVID-19 virus test and the result was negative. On 13Apr2021, the patient underwent COVID-19 virus test and the result was negative. The clinical outcome of the events extremely ill unable to move except to go to the bathroom, chills, migraine was recovered with sequelae at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Somnolence
Clinical narrative: Headache; Nauseous; Drowsy; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 13Apr2021 at 10:30 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 19Mar2021 at 08:45 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. On 13Apr2021 at 20:30, the patient experienced drowsy, headache and nauseous. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events drowsy, headache and nauseous were recovering at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Body aches.; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8737), via an unspecified route of administration in the left arm on 07Apr2021 at 11:30 (at the age of 59-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and COVID-19. The patient receives unspecified medications in two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 00:00, during 12 to 24 hours after injection, the patient experienced body aches and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body aches and fatigue were resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Body temperature, Chills, Fatigue, Hyperhidrosis
Clinical narrative: woke up with 101; had a fever of 101 and less than an hour after that it was 103.; Extreme chills; Aches all over; woke up soaked in sweat; lymph in my neck sore.; Armpit lymph was enlarged and painful; Armpit lymph was enlarged and painful; Tired; This is a spontaneous report from a contactable other healthcare professional, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 11:00 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history included hashimotos, rheumatoid arthritis and asthma. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) and thyroid (NATURE THROID); both from unspecified indication from unknown date. The patient previously took propylene glycol (MANUFACTURER UNKNOWN); for unspecified indication on unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 13:00, the patient felt tired the day after .On 04Apr2021 the patient experienced lymph in armpit was enlarged and painful. On 09Apr2021, one week post shot, the patient woke up soaked in sweat and lymph in neck sore.  Around 11:00, (exactly one week post shot to the hour) patient experienced extreme chills, aches all over. An hour later, at 12:00, patient had a fever of 101 and less than an hour after that it was 103. The patient slept most of the day and on 10Apr2021 woke up on the with 101 (fever). The patient underwent lab tests and procedures which included body temperature on 09Apr2021 at 12:00 and result was 101 (units unspecified) and body temperature on 09Apr2021, less than hour after 12:00 and result was 103 (units unspecified). On 10Apr2021, the patient underwent body temperature and the result was 101 (units unspecified). The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event tired, armpit lymph was enlarged and painful, woke up soaked in sweat, lymph in neck sore, extreme chills, aches all over  was unknown at the time of reporting. The clinical outcome of the event fever of 101 and 103 (on 09Apr2021) was not recovered and clinical outcome of fever (on 10Apr2021) was unknown at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: woke up with 101; had a fever of 101 and less than an hour after that it was 103.; Extreme chills; Aches all over; woke up soaked in sweat; lymph in my neck sore.; Armpit lymph was enlarged and painful; Armpit lymph was enlarged and painful; Tired; This is a spontaneous report from a contactable other healthcare professional, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 11:00 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history included hashimotos, rheumatoid arthritis and asthma. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) and thyroid (NATURE THROID); both from unspecified indication from unknown date. The patient previously took propylene glycol (MANUFACTURER UNKNOWN); for unspecified indication on unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 13:00, the patient felt tired the day after .On 04Apr2021 the patient experienced lymph in armpit was enlarged and painful. On 09Apr2021, one week post shot, the patient woke up soaked in sweat and lymph in neck sore.  Around 11:00, (exactly one week post shot to the hour) patient experienced extreme chills, aches all over. An hour later, at 12:00, patient had a fever of 101 and less than an hour after that it was 103. The patient slept most of the day and on 10Apr2021 woke up on the with 101 (fever). The patient underwent lab tests and procedures which included body temperature on 09Apr2021 at 12:00 and result was 101 (units unspecified) and body temperature on 09Apr2021, less than hour after 12:00 and result was 103 (units unspecified). On 10Apr2021, the patient underwent body temperature and the result was 101 (units unspecified). The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event tired, armpit lymph was enlarged and painful, woke up soaked in sweat, lymph in neck sore, extreme chills, aches all over  was unknown at the time of reporting. The clinical outcome of the event fever of 101 and 103 (on 09Apr2021) was not recovered and clinical outcome of fever (on 10Apr2021) was unknown at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Flushing, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 39-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0158), at the age of 39, via an unspecified route of administration, left arm, on Apr 13, 2021, at 10:30, single dose, for COVID-19 immunisation. Medical history included hypothyroidism and chronic active Epstein-Barr virus infection. The patient has no known allergies. Concomitant medications included levothyroxine sodium, Wellbutrin XL (bupropion hydrochloride), acyclovir sodium and multivitamins; all from unknown dates for unspecified indications. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 13, 2021, at 12:15, patient experienced fever (101.3ºF) with full body flush 2 hours post vaccination, which lasted 6 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On Apr 13, 2021, at 12:15, patient underwent lab test and procedure, which included body temperature: 101.3 F. The outcome of the fever (101.3ºF) and full body flush resolved on Apr 13, 2021, at 18:15. No follow-up attempts needed. No further information expected.